What is the main business of Smartmedics?

The main business activity of Smartmedics focuses on manufacture of medical and dental instruments and supplies.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on May 12, 2017.

Where is the headquarters located?

The headquarters is located at: ul. Puławska 12, 02-566 Warszawa.

Who is on the management board?

The management board consists of: Anna Elżbieta Aranowska Bablok (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 15,000 (approx. $4,052).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2023 to December 31, 2023.

What revenue was generated?

The company reported a revenue of $18,638 in 2023, which is a decrease of 98.3% compared to 2022.

Is the company profitable?

No, in 2023 the company was not profitable, reporting a net loss of $748,471. For comparison, in 2022 the loss was $481,636, meaning the company increased its loss by 46.5%.

What is the largest operating cost?

The largest operating cost category falls under external services. This category amounted to $367,963 in 2023, representing 53% of all operating expenses.

Smartmedicssp. z o.o.

Manufacture of medical and dental instruments and supplies

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2017-05-12

Share capital

15 000,00 PLN

Activity description

Smartmedics offers a handheld, wireless 12-lead ECG system for home and professional use. It includes a single-use ECG patch, a wireless Pebble recorder and an app for saving results and sharing them with a physician, supporting remote patient monitoring.

Registered address

ul. Puławska 12/3, 02-566 Warszawa, Poland

Website

smartmedics.pl

Social media

Electronic delivery address

AE:PL-29125-96423-CSRTB-21

Financials

The financial statement for 2024 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2023.

Results vs industry

Revenue

This companyUSD 18.64kMedianUSD 252.87kAverageUSD 4.60m

Net profit

This companyUSD -748.47kMedianUSD 8.64kAverageUSD 200.73k

Operating costs

This companyUSD 693.71kMedianUSD 267.10kAverageUSD 4.21m

Assets

This companyUSD 1.65mMedianUSD 228.68kAverageUSD 5.40m

Industry

Bank accounts

Registered as a VAT taxpayer on 2017-08-11. Active

No bank accounts reported to the VAT Taxpayer Register.

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

11 public aid cases recorded, with a total value of $1,885,370.

Grant date	Purpose	Gross amount	Granting body
Nov 23, 2023	De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)	$0$0	Prezes Zakładu Ubezpieczeń Społecznych
Feb 8, 2023	De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)	$137$137	Prezes Zakładu Ubezpieczeń Społecznych
Jan 12, 2023	De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)	$185$185	Prezes Zakładu Ubezpieczeń Społecznych

Tenders

No recorded participation in tenders.

Authorized Representatives

Anna Aranowska Bablok – President of the Management Board

Manner of representation

In the case of a one-person management board, the sole member of the management board is entitled to represent the company independently. In the case of a management board consisting of more than 1 (one) person, 2 (two) members of the management board acting jointly or 1 (one) member of the management board acting jointly with a commercial proxy are authorised to represent the company.

Supervisory board

Krzysztof Adam Laskowski – Supervisory Board Member

Wojciech Marek Bablok – Supervisory Board Member

Marek Jan Orłowski – Supervisory Board Member

Ownership

Owner	Shares	Share value	Stake
Adiuvo Management sp. z o.o.	150	$2,431.12	60%
Apollo Nala Swiss Ag	100	$1,620.75	40%

Beneficial owners

Person	Rights

Competitors

	Name	Revenue	Website
	Terapia Plussp. z o.o.	$40,180.80	terapia-plus.pl
	Advanced Medical EquipmentS.A.	$4,740.98	diabetomat.pl

Change history

Date	Event
2024-09-11	Share capital change (13,080.00 PLN → 15,000.00 PLN)
2022-06-06	Name change (Smartmedics Spółka Z Ograniczoną Odpowiedzialnośicą → Smartmedics)
2019-10-16	Address change (Ul. Smolna 4, 00-375, Warszawa → Ul. Puławska 12/3, 02-566, Warszawa)
2019-10-16	Share capital change (11,280.00 PLN → 13,080.00 PLN)
2019-03-14	Share capital change (9,000.00 PLN → 11,280.00 PLN)

FAQ

Last updated: 2026-04-23